TCL Archive BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal June 21, 2002
TCL Archive FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion October 9, 1987
